Tiotiu, Angelica
Mendez-Brea, Paula
Ioan, Iulia
Romero-Fernandez, Rodrigo
Oster, Jean Philippe
Hoang, Thi-cam-tu
Roux, Pauline
Ochoa-Gutierrez, Diana Carolina
Bonniaud, Philippe
de Blay, Frederic
Gonzalez-Barcala, Francisco-Javier
Article History
Accepted: 7 April 2022
First Online: 14 April 2022
Declarations
:
: Iulia Ioan, Rodrigo Romero-Fernandez, Thi-cam-tu Hoang and Diana Carolina Ochoa-Gutierrez have no conflicts of interest. Angelica Tiotiu reports speaker and consulting fees from ALK, AstraZeneca, GSK, Novartis and Sanofi outside the submitted work. Paula Méndez-Brea Paula reports personal fees from ALK, Allergy Therapeutics, Chiesi, GSK and Stallergenes outside the submitted work. Jean Philippe Oster reports speaker and consulting fees from AstraZeneca, GSK, Novartis and Sanofi outside the submitted work. Pauline Roux reports speaker and consulting fees from AstraZeneca, Chiesi, GSK and Novartis outside the submitted work. Philippe Bonniaud reports speaker and consulting fees from AstraZeneca, Chiesi, GSK, Novartis and Sanofi outside the submitted work. Frederic de Blay reports speaker and consulting fees from ALK, AstraZeneca, Chiesi, GSK, Novartis and Sanofi outside the submitted work. Francisco-Javier Gonzalez-Barcala has received speaker fees, consulting fees or research grants from ALK, AstraZeneca, Bial, Boehringer-Ingelheim, Chiesi, Gebro Pharma, GSK, Laboratorios Esteve, Menarini, Mundipharma, Novartis, Rovi, Roxall, Sanofi, Stallergenes and Teva.